Escalation and de-escalation in HER2 positive early breast cancer.

导出原文传递

翻译打印收藏纠错

作者： Maria Vittoria,Dieci ^[1] ; Grazia,Vernaci ^[2] ; Valentina,Guarneri ^[1]

作者单位： Department of Surgery, Oncology and Gastroenterology, University of Padova. ^[1] Medical Oncology 2, Istituto Oncologico Veneto IRCCS, Padova, Italy. ^[2]

主题词抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);乳腺肿瘤(Breast Neoplasms);临床试验, Ⅱ期(主题)(Clinical Trials, Phase II as Topic);临床试验, Ⅲ期(主题)(Clinical Trials, Phase III as Topic);女(雌)性(Female);人类(Humans);随机对照试验(主题)(Randomized Controlled Trials as Topic)

DOI 10.1097/CCO.0000000000000492

PMID 30325338

发布时间 2020-02-12

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览6

Current opinion in oncology

2019年31卷1期

35-42页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Escalation and de-escalation in HER2 positive early breast cancer.

Current opinion in oncology

相似文献

Current opinion in oncology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Escalation and de-escalation in HER2 positive early breast cancer.

Current opinion in oncology

相似文献

Current opinion in oncology

相关期刊

检索历史清除